Immuneed’s Post

Are you heading to Asembia's #AXS24 Summit later this month? Archbow's Subject Matter Experts and our colleagues from Valuate Health Consultancy and Entrée Health collaborated to create a checklist to help #marketaccess teams prepare for the conference. If you're attending, be sure to join us for a panel discussion on "Optimizing Market Access and Commercialization for New Biotech Product Launches." Details are on the last page of the PDF below. #pharma #biotech

#WeAreGenedata stories: meet some of the people driving Genedata's success. Lope, Scientific Consultant in our Basel office, explains how Genedata successfully bridges the gap between the scientific and technology worlds - and why this is unique in the biopharma R&D world. Discover more #WeAreGenedata stories: https://buff.ly/3JS2Aox #DigitalizingBiopharma #JoinGenedata

⚠️ The Scalability Cliff: Stumbling from Lab to Clinical and Market Scale ⚠️ Success at lab scale doesn’t guarantee smooth sailing on a pilot scale for #clinical development and ultimately a #commercial scale. The "scalability cliff" is where promising projects can falter. 💡 bespark*bio’s Solution: Early-stage Planning for Seamless Tech Transfer With scalability integrated into each process development stage, bespark*bio smoothens your path from non-GMP to #GMP production. Our robust, reproducible processes - backed by detailed descriptions and reports - help your team to scale effectively while preserving the unique qualities of your product. Our GMP alliances further streamline #TechnologyTransfer, making the leap to commercial production seamless. 🚀 The Result: Smoother Scaling, Preserved Product Integrity Through careful planning and strategic #partnerships, we help your project navigate the #scalability cliff, accelerating progress to clinical and market success. #Biotech, #Pharma, #LifeSciences, #ProcessDevelopment, #Innovation,#ViralVectors, #GeneTherapy, #GeneAndCellTherapy

🔬🧫Cells are the building blocks of innovation in drug development. However, the handling of cells is a delicate balance of speed and precision! Our Cold Chain Solutions keep things chill, ensuring highest quality in every process step. Discover more: https://hubs.ly/Q02vjwS60 #CoolCells #CellBanking #ColdChainSolutions #ColdChainManagement #PioneeringBiopharma

A year ago, we at PAIA embarked on a new journey: we launched our first assay kits for early developability assessments of antibodies. While we knew this was a highly relevant topic, we didn’t anticipate how quickly it would progress. 🚀 What surprised us most was how rapidly Big Pharma moved into evaluation of this new technology. Today, more than half of the top 10 companies is actively working on implementing our assays. And what's most fun: this is often a real exchange, which helps us to better understand the challenges and learn which additional assays are needed. So, why are smaller companies more cautious in adopting early developability screening, despite recognizing its importance? Yes, it involves extra work and resources are limited, but it’s never been more affordable or simpler to implement (and without capex). Now is the perfect time to start a conversation with us! 📞 https://lnkd.in/enZjuaky #developability #antibodydiscovery #leadoptimization #screening

🚀 Kick off Conf42: Platform Engineering with an exciting opening talk by Amit Taneja that will reshape how we think about technology in the pharma industry. 🌐https://lnkd.in/eJrMnJGS Discover how cutting-edge AI-driven platforms are revolutionizing drug discovery and engineering the future of healthcare. 📅 Don’t miss the first session on **September 5, 2024**—it’s a must-attend for anyone passionate about tech and innovation! #Conf42 #PlatformEngineering #PharmaTech #AIinPharma #TechInnovation #DrugDiscovery #HealthTech #AIPlatforms #EngineeringFuture #DigitalHealth #Biotech #PharmaInnovation #TechInPharma #AIRevolution #HealthcareInnovation #LifeSciences #MachineLearning #BiomedicalEngineering #TechConference #FutureOfMedicine

With capital preservation top-of-mind, and clinical success more challenging than ever, we’ve seen a significant uptick in demand for our services which focus on optimizing the relationship between Sponsor and CRO.   As we go about supporting our current clients, we thought we’d share with our network how we support sponsors to get the most from their clinical outsourcing activities 👇 #drugdevelopment #biotech #innovation #clinicalresearch #lifesciences

🚀 Breaking Down Data Silos to Accelerate Drug Development with SciNote 🚀 In the fast-paced world of drug discovery & development, time is of the essence. At SciNote, we're dedicated to helping teams overcome one of the biggest challenges in this industry: data silos. 🧩 When data is fragmented across various systems and departments, it can lead to inefficiencies, delays, and missed opportunities. That’s where SciNote comes in, providing a unified platform that integrates all your data, streamlines workflows, and fosters seamless collaboration. 🔍 Here’s how SciNote can make a difference: Centralized Data Management: Bring all your research data into one accessible location, eliminating the need for disparate systems and manual data transfer. Enhanced Collaboration: Facilitate real-time sharing and communication across teams, ensuring that everyone has access to the latest information and insights. Accelerated Decision-Making: With a holistic view of your data, make faster, more informed decisions to expedite your drug development process. Regulatory Compliance: Maintain rigorous standards and documentation with built-in compliance features to meet industry regulations effortlessly. Our goal is simple: to help you reduce time to market for your drug candidates, so you can focus on what truly matters—bringing life-saving treatments to those in need. Discover how SciNote can transform your drug development journey. Connect with us today and let’s break down those data silos together! 💡🔬 #DrugDevelopment #SciNote #DataIntegration #LifeSciences #Innovation #Research #Pharma #TechInPharma

As the #BIO2024 Conference approaches, iNGENū CRO is here to support companies navigating the complex landscape of biotech innovation and regulatory compliance. 🔬 Why partner with iNGENū? Cost Efficiency: Our unique business model reduces clinical trial costs by up to 70%, democratizing access to high-quality research. Regulatory Expertise: We offer comprehensive support for FDA, EMA, TGA, and MHRA regulatory requirements, ensuring your projects advance smoothly and swiftly. The Australian Advantage: Leveraging fast track regulatory processes and significant R&D tax incentives in Australia, we provide a strategic advantage in bringing products to trial faster and more cost-effectively. Even if you're not at BIO2024 and looking to explore new strategic partnerships or need advice on navigating FDA-centric clinical trials, we're here to help you achieve your research goals with our full suite of services from Phase 1 to Phase 3 trials. Reach out to learn more about how our innovative approaches can tailor support for your needs during and beyond BIO2024. #Biotechnology #ClinicalTrials

Want to learn how pharma is accelerating research by accessing and leveraging biobank data? Register for Lifebit's next webinar below!